CosmicTaco

Indian Pharma Stocks Surge Amid Tariff Relief

CosmicTaco · 2025-04-03T10:58:21.107504+05:30

- Shares of Indian pharmaceutical companies with significant US exposure surged 3%-13% after Trump refrained from imposing specific tariffs on the sector. - Trump announced reciprocal tariffs on over 60 nations, but pharmaceuticals were excluded, providing relief to the sector. - Analysts suggest the exclusion may be temporary, but it has brought positive sentiment to the market. - India currently imposes a 10% tariff on US pharma imports, while the US imposes none on Indian imports. - Stocks like Gland Pharma, Aurobindo Pharma, Dr. Reddy's, and Sun Pharma are in focus due to their significant US market exposure. Source: [Mint](https://www.livemint.com/market/stock-market-news/trump-reciprocal-tariffs-pharma-shares-rise-up-to-13-on-tariff-exemption-gland-pharma-aurobindo-pharma-lead-gainers-11743650617027.html), [News 18](https://www.news18.com/business/markets/sun-pharma-gland-pharma-other-pharma-stocks-in-focus-after-exemption-from-trumps-tariffs-9284910.html), [Moneycontrol](https://www.moneycontrol.com/news/business/markets/pharma-sector-may-see-relief-buying-on-exclusion-from-trump-s-reciprocal-tariffs-zydus-dr-reddy-s-in-focus-12983158.html)

Shares of Indian pharmaceutical companies with significant US exposure surged 3%-13% after Trump refrained from imposing specific tariffs on the sector.
Trump announced reciprocal tariffs on over 60 nations, but pharmaceuticals were excluded, providing relief to the sector.
Analysts suggest the exclusion may be temporary, but it has brought positive sentiment to the market.
India currently imposes a 10% tariff on US pharma imports, while the US imposes none on Indian imports.
Stocks like Gland Pharma, Aurobindo Pharma, Dr. Reddy's, and Sun Pharma are in focus due to their significant US market exposure.

Source: Mint, News 18, Moneycontrol